123 related articles for article (PubMed ID: 37774805)
1. FGF21 protects against doxorubicin-induced cardiotoxicity by inhibiting connexin 43 ubiquitination.
Huang Y; Wei C; Li P; Shao Y; Wang M; Wang F; Niu G; Sun K; Zhang Q; Gou Z; Yan X
Free Radic Biol Med; 2023 Nov; 208():748-758. PubMed ID: 37774805
[TBL] [Abstract][Full Text] [Related]
2. Connexin 43 hyper-phosphorylation at serine 282 triggers apoptosis in rat cardiomyocytes via activation of mitochondrial apoptotic pathway.
Fu ZP; Wu LL; Xue JY; Zhang LE; Li C; You HJ; Luo DL
Acta Pharmacol Sin; 2022 Aug; 43(8):1970-1978. PubMed ID: 34931018
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1/LKB1/AMPK pathway.
Wang S; Wang Y; Zhang Z; Liu Q; Gu J
Cell Death Dis; 2017 Aug; 8(8):e3018. PubMed ID: 28837153
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21 protects rat cardiomyocytes from endoplasmic reticulum stress by promoting the fibroblast growth factor receptor 1-extracellular signal‑regulated kinase 1/2 signaling pathway.
Liang P; Zhong L; Gong L; Wang J; Zhu Y; Liu W; Yang J
Int J Mol Med; 2017 Nov; 40(5):1477-1485. PubMed ID: 28949374
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinase OTUB1 regulates doxorubicin-induced cardiotoxicity via deubiquitinating c-MYC.
Xu F; Zang T; Chen H; Zhou C; Wang R; Yu Y; Shen L; Qian J; Ge J
Cell Signal; 2024 Jan; 113():110937. PubMed ID: 37871668
[TBL] [Abstract][Full Text] [Related]
6. Connexin 43 dephosphorylation contributes to arrhythmias and cardiomyocyte apoptosis in ischemia/reperfusion hearts.
Xue J; Yan X; Yang Y; Chen M; Wu L; Gou Z; Sun Z; Talabieke S; Zheng Y; Luo D
Basic Res Cardiol; 2019 Aug; 114(5):40. PubMed ID: 31463533
[TBL] [Abstract][Full Text] [Related]
7. Connexin 43-serine 282 modulates serine 279 phosphorylation in cardiomyocytes.
Sun Z; Yang Y; Wu L; Talabieke S; You H; Zheng Y; Luo D
Biochem Biophys Res Commun; 2019 Jun; 513(3):567-572. PubMed ID: 30981509
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice.
Ikeda Y; Aihara K; Akaike M; Sato T; Ishikawa K; Ise T; Yagi S; Iwase T; Ueda Y; Yoshida S; Azuma H; Walsh K; Tamaki T; Kato S; Matsumoto T
Mol Endocrinol; 2010 Jul; 24(7):1338-48. PubMed ID: 20501642
[TBL] [Abstract][Full Text] [Related]
9. Serum and glucocorticoid inducible kinase 1 modulates mitochondrial dysfunction and oxidative stress in doxorubicin-induced cardiomyocytes by regulating Hippo pathway via Neural precursor cell-expressed developmentally down-regulated 4 type 2.
Zou Z; Zhao T; Zeng Z; An Y
Hum Exp Toxicol; 2023; 42():9603271231158039. PubMed ID: 36781297
[TBL] [Abstract][Full Text] [Related]
10. Connexin43 dephosphorylation at serine 282 is associated with connexin43-mediated cardiomyocyte apoptosis.
Yang Y; Yan X; Xue J; Zheng Y; Chen M; Sun Z; Liu T; Wang C; You H; Luo D
Cell Death Differ; 2019 Jul; 26(7):1332-1345. PubMed ID: 30770876
[TBL] [Abstract][Full Text] [Related]
11. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.
Qi W; Boliang W; Xiaoxi T; Guoqiang F; Jianbo X; Gang W
Biomed Pharmacother; 2020 Feb; 122():109547. PubMed ID: 31918264
[TBL] [Abstract][Full Text] [Related]
12. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway.
Cheng Y; Wu X; Nie X; Wu Y; Zhang C; Lee SM; Lv K; Leung GP; Fu C; Zhang J; Li J
Phytomedicine; 2022 Nov; 106():154407. PubMed ID: 36070662
[TBL] [Abstract][Full Text] [Related]
13. Sirt6 protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting P53/Fas-dependent cell death and augmenting endogenous antioxidant defense mechanisms.
Wu S; Lan J; Li L; Wang X; Tong M; Fu L; Zhang Y; Xu J; Chen X; Chen H; Li R; Wu Y; Xin J; Yan X; Li H; Xue K; Li X; Zhuo C; Jiang W
Cell Biol Toxicol; 2023 Feb; 39(1):237-258. PubMed ID: 34713381
[TBL] [Abstract][Full Text] [Related]
14. C1qTNF-related protein-6 protects against doxorubicin-induced cardiac injury.
Zheng WF; Zhang SY; Ma HF; Chang XW; Wang H
J Cell Biochem; 2019 Jun; 120(6):10748-10755. PubMed ID: 30719766
[TBL] [Abstract][Full Text] [Related]
15. Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity.
Zhang X; Zhu JX; Ma ZG; Wu HM; Xu SC; Song P; Kong CY; Yuan YP; Deng W; Tang QZ
Int J Biol Sci; 2019; 15(3):556-567. PubMed ID: 30745842
[TBL] [Abstract][Full Text] [Related]
16. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
[TBL] [Abstract][Full Text] [Related]
17. Cardiomyocyte FGF signaling is required for Cx43 phosphorylation and cardiac gap junction maintenance.
Sakurai T; Tsuchida M; Lampe PD; Murakami M
Exp Cell Res; 2013 Aug; 319(14):2152-65. PubMed ID: 23742896
[TBL] [Abstract][Full Text] [Related]
18. PKCɛ mediates serine phosphorylation of connexin43 induced by lysophosphatidylcholine in neonatal rat cardiomyocytes.
Liao CK; Cheng HH; Wang SD; Yeih DF; Wang SM
Toxicology; 2013 Dec; 314(1):11-21. PubMed ID: 23973256
[TBL] [Abstract][Full Text] [Related]
19. Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy.
Dhingra R; Rabinovich-Nikitin I; Rothman S; Guberman M; Gang H; Margulets V; Jassal DS; Alagarsamy KN; Dhingra S; Valenzuela Ripoll C; Billia F; Diwan A; Javaheri A; Kirshenbaum LA
Circulation; 2022 Sep; 146(12):934-954. PubMed ID: 35983756
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen sulfide alleviates mitochondrial damage and ferroptosis by regulating OPA3-NFS1 axis in doxorubicin-induced cardiotoxicity.
Wang Y; Ying X; Wang Y; Zou Z; Yuan A; Xiao Z; Geng N; Qiao Z; Li W; Lu X; Pu J
Cell Signal; 2023 Jul; 107():110655. PubMed ID: 36924813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
